January 18-22, 2016 | Town and Country Resort Hotel | SAN DIEGO, CA 
January 18-22, 2016 | Town and Country Resort Hotel | SAN DIEGO, CA 

Pipeline Four Icon Pipeline Four Header 

Cambridge Healthtech Institute’s 3rd Annual
Applying Expression Platforms
Transient, Stable or Both?
January 21-22, 2016


Speed, limiting risk and protein quality are often cited as advantages of transient protein production (TPP), while stable transfection – the longer and more complex process – has the advantage of producing long-term expression of the protein of interest. The rapidly increasing need for recombinant proteins necessitates further improvements in both technologies.

Cambridge Healthtech Institute’s 3rd Annual Applying Expression Platforms conference convenes protein expression specialists who share their experiences with the differences, tradeoffs, advantages and improvements in producing recombinant proteins in transient and stable production systems, along with the systems’ advantages and disadvantages and when to use both.

Preliminary Agenda 


TRANSIENT PROTEIN PRODUCTION

A Comparison of Two Methods for the Gram-Scale Production of Recombinant IgG in Transiently Transfected Cultures of HEK-293 and CHO-S Cells

Christopher W. Kemp, Ph.D., President, Kempbio, Inc.

The Flexibility and Throughput of a Transient Protein Production Core Group Efficiently Supports the Protein Demands for Early Drug Discovery Studies

Richard Altman, MS, Research Scientist, Molecular Sciences, Alexion Pharmaceuticals


CHO CELLS

New Workflow Platform for High-Throughput Cell Line Development

Christian Bender, Ph.D., Computational Biologist, Global Drug Discovery, Global Biologics, Bayer HealthCare

Epigenetic Marks Enable Rejection of Unstable Chinese Hamster Ovary Cell Lines

Ulrich Goepfert, Ph.D., Principal Scientist, Cell Line & Molecular Development, Roche Innovation Center Penzberg


Call for Speakers


We invite presentation proposals on the following preliminary topics: 

  • CHO cell lines
  • HEK293 cell lines
  • Transfection optimization
  • Transfection performance
  • Cell culture optimization
  • Increasing speed and lowering cost
  • Stable expression vs. transient expression
  • Establishing an efficient production facility

Please click here to submit a speaking proposal for review.

Deadline for submission: July 24, 2015 

All proposals are subject to review by the Scientific Advisory Committee to ensure the overall quality of the conference program. Please note that due to limited speaking slots, preference will be given to abstracts from those within pharmaceutical and biopharmaceutical companies, regulators and those from academic centers. Additionally, as per CHI policy, a select number of vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships. 




For questions about the meeting, please contact: 

Mary Ann Brown
Executive Director, Conferences
Cambridge Healthtech Institute
Phone: 781-972-5497
Email: mabrown@healthtech.com 

For partnering & sponsorship information, please contact: 

Companies A-K
Jason Gerardi
Manager, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5452
Fax: 781-972-5470
Email: jgerardi@healthtech.com 

Companies L-Z
Carol Dinerstein
Director, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5471
Fax: 781-972-5470
Email: dinerstein@healthtech.com